The Scripps Translational Science Institute (STSI) of San Diego, has joined a national consortium of research institutions headed by The Jackson Laboratory to build a library of primary human tumors with the goal of developing highly targeted cancer therapies.
In its role as a consortium member, STSI will provide solid human tumor samples to JAX, which will graft them into mouse models for scientific study. STSI scientists will then have access to the models to conduct research on how to better understand and treat cancer, including the potential for tumor-specific therapies.
JAX will perform the initial genomic characterization of the tumors and will share this data with all participating institutions. STSI is a major research collaboration involving the nonprofit Scripps Health system and The Scripps Research Institute, both of San Diego.
JAX launched the Primary Human Tumor Consortium in 2009. Other participating institutions include the University of Florida, the Swedish Neuroscience Institute in Seattle and UC Davis Cancer Center.